
Opinion|Videos|June 10, 2024
Identifying the Right Patient Population for PSMA-PET Imaging
Experts on prostate cancer offer clinical insights on identifying the appropriate patients for PSMA-PET imaging.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What are the current recommendations in terms of initial staging and evaluation and monitoring of prostate cancer and at recurrence? Are you adopting these recommendations in your practice?
- Discuss the value of PSMA-PET imaging in patients with intermediate unfavorable and above disease.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
4
FDA approves first-line Zenflow system for the treatment of BPH
5




















